Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells
Denis Selimovic1, Benjamin B O W Porzig, Abdelouahid El-Khattouti
1Institut National de la Santé et de la Recherche Médicale, U 977, France.
Abstract:
Generally, both endoplasmic reticulum (ER) stress and mitochondrial dysregulation are a potential therapeutic target of anticancer agents including bortezomib. The treatment of melanoma cells with bortezomib was found to induce apoptosis together with the upregulation of Noxa, Mcl-1, and HSP70 proteins, and the cleavage of LC3 and autophagic formation. Also, bortezomib induced ER-stress as evidenced by the increase of intracellular Ca(2+) release. In addition, bortezomib enhanced the phosphorylation of inositol-requiring transmembrane kinase and endonuclease 1α (IRE1α), apoptosis signal-regulating kinase 1 (ASK1), c-jun-N-terminal kinase (JNK) and p38, and the activation of the transcription factors AP-1, ATF-2, Ets-1, and HSF1. Bortezomib-induced mitochondrial dysregulation was associated with the accumulation of reactive oxygen species (ROS), the release of both apoptosis inducing factor (AIF) and cytochrome c, the activation of caspase-9 and caspase-3, and cleavage of Poly (ADP-ribose) polymerase (PARP). The pretreatment of melanoma cells with the inhibitor of caspase-3 (Ac-DEVD-CHO) was found to block bortezomib-induced apoptosis that subsequently led to the increase of autophagic formation. In contrast, the inhibition of ASK1 abrogated bortezomib-induced autophagic formation and increased apoptosis induction. Furthermore, the inhibition of JNK, of HSP70 also increased apoptosis induction without influence of bortezomib-induced autophagic formation. Based on the inhibitory experiments, the treatment with bortezomib triggers the activation of both ER-stress-associated pathways, namely IRE1α-ASK1-p38-ATF-2/ets-1-Mcl-1, and IRE1α-ASK1-JNK-AP-1/HSF1-HSP70 as well as mitochondrial dysregulation-associated pathways, namely ROS-ASK1-JNK-AP-1/HSF1-HS70, and AIF-caspase-3-PARP and Cyt.c, and caspase-9-caspase-3-PARP. Taken together, our data demonstrates for the first time the molecular mechanisms, whereby bortezomib triggers both apoptosis and autophagic formation in melanoma cells.
Insights
Bortezomib induces apoptosis and autophagy in melanoma cells by activating endoplasmic reticulum stress and mitochondrial pathways. This study elucidates the molecular mechanisms behind bortezomib
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Endoplasmic reticulum (ER) stress and mitochondrial dysregulation are key targets for anticancer agents.
- Bortezomib is a therapeutic agent with known anticancer properties.
Purpose of the Study:
- To elucidate the molecular mechanisms by which bortezomib induces apoptosis and autophagic formation in melanoma cells.
- To investigate the roles of ER stress and mitochondrial pathways in bortezomib's effects.
Main Methods:
- Treatment of melanoma cells with bortezomib.
- Analysis of protein expression (Noxa, Mcl-1, HSP70, LC3).
- Assessment of ER stress markers (intracellular Ca(2+) release) and mitochondrial pathways (ROS, AIF, cytochrome c).
- Inhibition studies using caspase-3, ASK1, JNK, and HSP70 inhibitors.
Main Results:
- Bortezomib induced apoptosis, ER stress, and autophagic formation in melanoma cells.
- Key signaling pathways including IRE1α, ASK1, JNK, p38, and transcription factors were activated.
- Mitochondrial dysregulation involved ROS accumulation, AIF and cytochrome c release, and caspase activation.
- Inhibitor studies revealed distinct roles for caspase-3, ASK1, JNK, and HSP70 in modulating apoptosis and autophagy.
Conclusions:
- Bortezomib triggers apoptosis and autophagic formation in melanoma cells through complex interplay of ER stress and mitochondrial dysregulation pathways.
- The study provides novel insights into the molecular mechanisms of bortezomib action in melanoma.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Extrinsic Apoptotic Pathway


